| ²é¿´: 318 | »Ø¸´: 5 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| ¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß ß÷ß÷9761 µÄ 7 ¸ö½ð±Ò £¬»ØÌû¾ÍÁ¢¼´»ñµÃ 1 ¸ö½ð±Ò£¬Ã¿ÈËÓÐ 1 ´Î»ú»á | |||
ß÷ß÷9761ͳæ (³õÈëÎÄ̳)
|
[½»Á÷]
¡¾ÇóÖú¡¿¼±ÇóһƪӢÎÄÎÄÏ×
|
||
|
±¾ÈËÖ»ÓÐÎÄÕÂÃû³Æ°¡£¬ÊµÔÚÕÒ²»µ½È«ÎÄ£¬ÄÜÕÒµ½µÄ³æ³æÃǰïæ°¡£¡Ð»Ð» Liversidge EM. Nanocrystals: resolving pharmaceutical formulation issues associated with poorly water-soluble compounds in: J.J. Marty (Ed.), Particles, Marcel Dekker, Orlando, 2002. |
» ²ÂÄãϲ»¶
085601²ÄÁϹ¤³ÌÕÒµ÷¼Á
ÒѾÓÐ11È˻ظ´
×Ü·Ö293Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
334·Ö Ò»Ö¾Ô¸ÎäÀí ²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
327Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
329Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
275Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
309Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
297Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸ÄϺ½ 335·Ö | 0856 | GPA 4.07 | ÓпÆÑоÀú
ÒѾÓÐ6È˻ظ´
ß÷ß÷9761
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 192.3
- ºì»¨: 1
- Ìû×Ó: 36
- ÔÚÏß: 5Сʱ
- ³æºÅ: 588244
- ×¢²á: 2008-08-22
- רҵ: Ò©¼Áѧ
2Â¥2010-03-02 13:12:12
amisking:ÑϽû·¢´¿±íÇéÌù¡£ 2010-03-02 22:07
![]() |
3Â¥2010-03-02 13:13:03
ß÷ß÷9761
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 192.3
- ºì»¨: 1
- Ìû×Ó: 36
- ÔÚÏß: 5Сʱ
- ³æºÅ: 588244
- ×¢²á: 2008-08-22
- רҵ: Ò©¼Áѧ
4Â¥2010-03-03 21:14:17
ß÷ß÷9761
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 192.3
- ºì»¨: 1
- Ìû×Ó: 36
- ÔÚÏß: 5Сʱ
- ³æºÅ: 588244
- ×¢²á: 2008-08-22
- רҵ: Ò©¼Áѧ
5Â¥2010-03-03 21:27:45
ß÷ß÷9761
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 192.3
- ºì»¨: 1
- Ìû×Ó: 36
- ÔÚÏß: 5Сʱ
- ³æºÅ: 588244
- ×¢²á: 2008-08-22
- רҵ: Ò©¼Áѧ
6Â¥2010-03-03 21:28:27














»Ø¸´´ËÂ¥